Sera Prognostics, Inc. (SERA) vs SkinHealth Systems Inc. (SKIN)
A side-by-side comparison of Sera Prognostics, Inc. and SkinHealth Systems Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SERA
Sera Prognostics, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SKIN
SkinHealth Systems Inc.
$0.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SERA vs SKIN
growth of $100 · dividends reinvested · last 5ySERA -83.2% (-30.0%/yr)SKIN -96.7% (-49.6%/yr)SERA compounded faster over this window
Log scale — wide-divergence pair
SERA SKIN
SERA vs SKIN: by the numbers
- •SERA is the larger company ($78M vs $76M market cap).
- •Both run net losses; SKIN's is the smaller (-9.79% vs -47475.71% net margin).
- •SERA grew revenue faster over the past five years (9.73% vs 9.24% CAGR).
Metrics side by side
Valuation
| Metric | SERA | SKIN |
|---|---|---|
| P/S ratio | 1118.45 | 0.26 |
| P/B ratio | 1.32 | 1.37 |
| EV / EBITDA | N/A | 10.31 |
| FCF yield | N/A | 21.91% |
Profitability
| Metric | SERA | SKIN |
|---|---|---|
| Gross margin | -102.47% | 66.34% |
| Operating margin | -45066.67% | -1.49% |
| Net margin | -47475.71% | -9.79% |
| ROE | -55.97% | -51.09% |
| ROIC | -59.79% | -1.02% |
Growth (annualized)
| Metric | SERA | SKIN |
|---|---|---|
| Revenue CAGR (5Y) | 9.73% | 9.24% |
| Total return CAGR (5Y) | -28.91% | -53.07% |
Frequently asked
- Which has grown faster, SERA or SKIN?
- Over the past five years, SERA grew revenue faster — SERA at a 9.73% CAGR versus SKIN at 9.24%.
- How have SERA and SKIN total returns compared?
- Over the past 5 years, SERA delivered -28.91% and SKIN delivered -53.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Sera Prognostics ROESkinHealth Systems ROESera Prognostics operating marginSkinHealth Systems operating marginSera Prognostics revenue growthSkinHealth Systems revenue growthSera Prognostics free cash flowSkinHealth Systems free cash flow
Sera Prognostics & SkinHealth Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.